tiprankstipranks
Trending News
More News >
Inhibikase Therapeutics (IKT)
NASDAQ:IKT

Inhibikase Therapeutics (IKT) Market Cap & Net Worth

Compare
187 Followers

Inhibikase Therapeutics Market Cap

Inhibikase Therapeutics has a market cap or net worth of $189.18M as of Feb 06, 2026. Its market cap has increase by 776.44% in one year.
Market Cap
$189.18M
Enterprise Value
$72.49M
1-Year Change
776.44%
Category
Micro (Under 300M)
Stock Price
$1.56

Market Cap Chart

Market Cap History
Date
Market Cap
% Change
Feb 04, 2026
110.76M-1.27%
Feb 03, 2026
112.18M+0.64%
Feb 02, 2026
111.47M+4.67%
Jan 30, 2026
106.50M-4.46%
Jan 29, 2026
111.47M-1.26%
Jan 28, 2026
112.89M-5.92%
Jan 27, 2026
119.99M+2.42%
Jan 26, 2026
117.15M-5.17%
Jan 23, 2026
123.55M-3.33%
Jan 22, 2026
127.81M+2.86%